InvestorWire NewsRoom


Healthy Extracts Inc. (HYEX) Announces Association Of Dr. Kahn With The Healthy Extracts Inc. Medical Board
May 12, 2021

Healthy Extracts Inc. (HYEX) Announces Association Of Dr. Kahn With The Healthy Extracts Inc. Medical Board

  • Healthy Extracts Inc. announces the addition of Dr. Joel Kahn, M.D., a world-renowned, triple board-certified cardiology specialist to its medical board
  • Dr. Kahn has personally conducted clinical studies that confirm the benefits of Citrus Bergamot SuperFruit(TM) for cardiovascular health
  • Citrus Bergamot SuperFruit(TM), the main ingredient in BergametNA’s product line, is the super fruit alternative to prescribed cholesterol medications 

Healthy Extracts (OTCQB: HYEX), through its developing and acquiring complementary companies, is engaged in manufacturing plant-based formulations dedicated to heart and Brain health. With its focus towards strengthening its position in the multibillion-dollar nutraceuticals market, the company has already launched its science-based BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiaries.

Healthy Extracts Inc. recently announced the addition of Dr. Joel Kahn, M.D., a world-renowned, triple board-certified cardiology specialist, to the company’s medical board. Dr. Kahn has used the BergametNA Citrus Bergamot SuperFruit on thousands of patients and approved the product’s cardiovascular health benefits of positive arterial age reversal and arterial flexibility ( 

Duke Pitts, director, president, and CEO of Healthy Extracts Inc. said that they were excited to welcome Dr. Kahn, one of the few triple-certified cardiologists in the U.S, to their company’s medical board. He further said Dr. Kahn’s decision to join the company’s medical board, based on the Kahn Center for Cardiac Longevity CIMT test results, was an exciting development. Duke Pitts also said that his addition to the company’s already talented team of specialized doctors will be instrumental in expanding their doctor-to-doctor and consumer sales.

For more information on heart health, watch Dr. Kahn’s press release video.

Dr. Kahn, whose cardiology career spans 30 years, has been studying natural health, integrative cardiology, and wellness cardiology over the last decade. He expressed his pleasure in joining the Healthy Extracts Inc. medical board. He also said that physicians across North America should be educated about the benefits of BergametNA’s product formulations and how it can assist doctors in treating patients naturally. Dr. Kahn has personally conducted clinical studies that confirm the virtues of the super fruit Citrus Bergamot SuperFruit, the main ingredient in BergametNA’s product line. 

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at 

About Healthy Extracts Inc.

“Live Life Young Again”

Healthy Extracts Inc. (OCTQB: HYEX) serves as a platform for developing and acquiring complementary companies that feature science-forward, clinically proven, plant-based and proprietary products in select high-margin and high-growth categories within the multibillion-dollar nutraceuticals market – the first two multimillion-dollar examples of which have already been launched.

Company subsidiaries BergametNA(TM) and Ultimate Brain Nutrients(TM) (“UBN”) are providers of nutraceutical natural heart and brain health supplements, including the only heart health supplement containing Citrus Bergamot SuperFruit(TM), the highest quality and concentration of polyphenols and flavonoids available anywhere in the world and exclusive to BergametNA in North America and backed by 17 clinical studies. UBN’s KETONOMICS(R) proprietary formulations improve brain health, including memory, cognition, focus and neuro-energy, and have multiple intellectual property license opportunities for monetizing the company’s portfolio. UBN has six unique formulation patents – two issued and four pending.

For more information visit:, or

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.

Healthy Extracts Inc.
Las Vegas, Nevada
[email protected]

Corporate Communications:InvestorBrandNetwork (“IBN”)
Los Angeles, California
310.299.1717 Office
[email protected]

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).